The Journal of Neuroimmune Pharmacology (JNIP) is the peer-reviewed journal of the Society on NeuroImmune Pharmacology. JNIP interfaces the disciplines of immunology, pharmacology and experimental neuroscience by acting as a platform for research discoveries into the pathogenesis and pharmacology of ...

The Journal of Neuroimmune Pharmacology (JNIP) is the peer-reviewed journal of the Society on NeuroImmune Pharmacology. JNIP interfaces the disciplines of immunology, pharmacology and experimental neuroscience by acting as a platform for research discoveries into the pathogenesis and pharmacology of brain disorders affecting the immune system. Original and interdisciplinary scientific contributions, concise "opinion," and broader reviews are welcome. Research areas reporting in JNIP intersect the disciplines of receptor cell signaling, drugs of abuse, neurodegenerative disorders, neurovirology, immunology, and neuropharmacology. Manuscripts must include original research germane to the immunology and pharmacology of human neurologic and neuropsychiatric disorders including substance abuse, depression, psychosis, Alzheimer's and Parkinson's disease, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, HIV-1 associated dementia, neuroendocrine and microbial infections, and immunological di